4//SEC Filing
DUGAN RICHARD W 4
Accession 0001209191-23-036280
CIK 0001347178other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:18 PM ET
Size
7.3 KB
Accession
0001209191-23-036280
Insider Transaction Report
Form 4
DUGAN RICHARD W
Director
Transactions
- Award
Common Stock
2023-06-08+17,307→ 97,700 total - Award
Stock Option (Right to Buy)
2023-06-08+33,960→ 33,960 totalExercise: $6.50Exp: 2033-06-07→ Common Stock (33,960 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001263499
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:18 PM ET
- Size
- 7.3 KB